DR. DAVID E WENG, MD
Osteopathic Medicine at Spring Hill Ln, Bethesda, MD
License number
Maryland D47203
Category
Osteopathic Medicine
Type
Medical Oncology
License number
Maryland 35074984W
Category
Osteopathic Medicine
Type
Medical Oncology
License number
Maryland C55735
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
9017 Spring Hill Ln, Bethesda, MD 20815
Phone
(301) 652-7370
(866) 858-1893 (Fax)
(866) 858-1893 (Fax)
Personal information
See more information about DAVID E WENG at radaris.comName
Address
Phone
9017 Spring Hill Ln, Chevy Chase, MD 20815
5101 River Rd, Bethesda, MD 20816
1221 Cleveland St, Baltimore, MD 21230
1143 Hamburg St, Baltimore, MD 21230
9017 Spring Hill Ct, Chevy Chase, MD 20815
Professional information
Dr. David E Weng, Chevy Chase MD - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
9017 Spring Hill Ln SUITE L, Chevy Chase 20815
(301) 398-5879 (Phone), (866) 858-1893 (Fax)
(301) 398-5879 (Phone), (866) 858-1893 (Fax)
Certifications:
Internal Medicine, 1995, Medical Oncology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1992
The Johns Hopkins Hospital
Natl Cancer Inst
Johns Hopkins University / School of Medicine
Graduated: 1992
The Johns Hopkins Hospital
Natl Cancer Inst
Method For Increasing The Antigen Presenting Ability Of Leukemia Cells
US Patent:
6358736, Mar 19, 2002
Filed:
Sep 22, 1999
Appl. No.:
09/401060
Inventors:
Peter A. Cohen - Bethesda MD
Brian J. Czerniecki - Haddenfield NJ
Gary K. Koski - Bethesda MD
David E. Weng - Bethesda MD
Charles Carter - Gaithersberg MD
John O. Ojeifo - Washington DC
Gretchen N. Schwartz - Wheaton MD
Brian J. Czerniecki - Haddenfield NJ
Gary K. Koski - Bethesda MD
David E. Weng - Bethesda MD
Charles Carter - Gaithersberg MD
John O. Ojeifo - Washington DC
Gretchen N. Schwartz - Wheaton MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 508
US Classification:
435326, 435 724, 435372, 435383
Abstract:
The present invention relates to methods of increasing the antigen presenting ability of leukemia cells by contacting them with an agent which increases the intracellular calcium level. Methods of treating leukemia are also disclosed.
Method For Inducing Monocytes To Exhibit The Phenotype Of Activated Myeloid Dendritic Cells
US Patent:
6010905, Jan 4, 2000
Filed:
Jun 30, 1997
Appl. No.:
8/885671
Inventors:
Peter A. Cohen - Bethesda MD
Brian J. Czerniecki - Haddenfield NJ
Gary K. Koski - Bethesda MD
David E. Weng - Bethesda MD
Charles Carter - Gaithersberg MD
John O. Ojeifo - Washington DC
Gretchen N. Schwartz - Wheaton MD
Brian J. Czerniecki - Haddenfield NJ
Gary K. Koski - Bethesda MD
David E. Weng - Bethesda MD
Charles Carter - Gaithersberg MD
John O. Ojeifo - Washington DC
Gretchen N. Schwartz - Wheaton MD
Assignee:
The United States of America as represented by the Department of Health
& Human Services - Washington DC
& Human Services - Washington DC
International Classification:
C12N 508
US Classification:
435372
Abstract:
The present invention relates to methods of increasing the antigen presenting ability of monocytes by contacting them with an agent which increases the intracellular calcium level. Methods of obtaining the monocytes are also disclosed. In addition, the present invention relates to methods of inducing bone marrow progenitor cells and endothelial cells to express molecules involved in generating immune responses. Methods of modulating the expression of molecules involved in generating immune responses are also disclosed, as are methods of treating cancer and leukemia.